None listed
Conditions
Interventions
Intervention1: CurQfen: Dose is 1g (500 mg x 2 capsules) of CurQfen
Route of administration: Oral
Frequency is only once in the study.
Control Intervention1: normal unformulated Curcumin: Dose: 1g (
Sponsors
Akay Flavours Aromatics PvtLtd
Eligibility
Inclusion criteria
Inclusion criteria: 1. Healthy volunteers of age 20 to 55 years of either sex who are not involved in any regular medication or supplementation. 2. Subjects who are willing to give their written informed consent and comply with the protocol requirements.
Exclusion criteria
Exclusion criteria: 1. Patient who took turmeric contained food 2 days prior to screening 2. Pregnant or lactating women. 3. Subjects with known hypersensitivity to the investigational products. 4. Subjects who have participated in any clinical trial in the past 1 month. 5. Any subjects found to have entered in to the study in violation of this protocol or if the subject is uncooperative during the study. 6. Any other condition that in the opinion of the investigator that does not justify the subjectâ??s participation in the trial
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Curcuminoids in bloodTimepoint: 24 Hours | — |
Secondary
| Measure | Time frame |
|---|---|
| Time of presence of curcuminoids in bloodTimepoint: 24 Hours | — |
Countries
India
Contacts
Public ContactDr Krishnakumar IM
Akay Flavours and Aromatics Pvt.Ltd
Outcome results
None listed